Asian Institute of Nephrology and Urology 
Dealstreet

Khaitan advises Asian Institute of Nephrology and Urology on sale of majority stake to Asia Healthcare Holdings

The deal amount is valued at ₹600 crore.

Bar & Bench

The Asian Institute of Nephrology and Urology Private Limited ("AINU") has sold the majority stake by way of secondary sale and primary issuance of shares to Asia Healthcare Holdings Pte. Ltd. for an overall deal value of ₹600 crore.

Khaitan & Co advised AINU, the selling shareholders (including the promoters) and the exiting fund, HealthQuad Fund I in this transaction.

The core team consisted of Mayank Singh (Partner), Kevin Peter (Counsel), Kairavi Shah (Principal Associate), Esha Chauhan (Senior Associate), Hitakshi Mahendru (Senior Associate) with closing assistance from Mohnish Singh (Associate).

Mayank Singh

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Follow Bar and Bench channel on WhatsApp

Download the Bar and Bench Mobile app for instant access to the latest legal news.

Also Read

MUDA case: Relief for CM Siddaramaiah as Bengaluru court accepts Lokayukta closure report

Delhi High Court moots committee to address encroachment, illegal hawkers, rickshaws at Chandni Chowk

Waqf Act 1995 does not oust civil courts' jurisdiction and confer omnibus jurisdiction on Waqf Tribunal: Supreme Court

Delhi High Court rejects Engineer Rashid's plea against terror funding charges

No ulterior motive: Kerala High Court clears State in Sprinklr data sharing controversy

SCROLL FOR NEXT